Daily Top News - July 23, 2020

llllllllll VTA-110 / Vita TherapVita Therapeutics receives Orphan Drug Designation from FDA for new novel treatment (PRNewswire) - Jul 23, 2020 - "Vita Therapeutics...announced today that it received orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for VTA-110, a novel regenerative therapy for the treatment of Duchenne's Muscular Dystrophy (DMD)...The company plans to continue to progress this treatment towards clinical trials and plans to bring it forward for other congenital muscular dystrophy diseases as well."